生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

未开盘 12-09 16:00:00 EST

1,101.87

-15.62

-1.40%

最高1,121.58	最低1,101.11	成交量7.80亿
今开1,117.52	昨收1,117.49	日振幅1.83%
总市值0.00	流通市值0.00	总股本0.00
成交额161.00亿	换手率--	流通股本0.00
市净率7.136554	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":1101.8693,"timestamp":1765313999999,"preClose":1117.4933,"halted":0,"volume":780345672,"delay":0,"changeRate":-0.013981,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-15.624023,"latestTime":"12-09 16:00:00 EST","open":1117.5214,"high":1121.5809,"low":1101.109,"amount":16100345709.922682,"amplitude":0.01832,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765377000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.136554,"peRate":-126.259239,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139/wiki","defaultTab":"wiki","newsList":[{"id":"1184302088","title":"IDEAYA Biosciences 提交 Ide574 的 IND 申请，成为潜在的首个 Kat6/7 双重抑制剂，用于治疗乳腺癌和肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1184302088","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184302088?lang=zh_cn&edition=full","pubTime":"2025-12-10 19:01","pubTimestamp":1765364472,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences 提交 Ide574 的 IND 申请，成为潜在的首个 Kat6/7 双重抑制剂，用于治疗乳腺癌和肺癌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"1102748254","title":"港股创新药概念股盘初普跌！歌礼制药-B跌近6%、金斯瑞生物科技跌近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102748254","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102748254?lang=zh_cn&edition=full","pubTime":"2025-12-10 09:44","pubTimestamp":1765331074,"startTime":"0","endTime":"0","summary":"12月10日，港股创新药概念股盘初普跌，$歌礼制药-B(01672)$跌近6%，$金斯瑞生物科技(01548)$跌近5%，$再鼎医药(09688)$跌超3%，$康方生物(09926)$、$药明康德(00013)$、$药明生物(02269)$跌超2%.","market":"hk","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","LU0572944931.SGD","ZLAB","IE00B0JY6N72.USD","BK1141","LU1880383366.USD","HK0000306701.USD","BK4588","LU0417516571.SGD","BK1515","BK4585","LU0307460666.USD","LU1242518857.USD","BK1610","LU2039709279.SGD","LU0823426308.USD","HK0000306685.HKD","HK0000320223.HKD","LU0456846285.SGD","LU1242518931.SGD","BK1589","LU0320764599.SGD","LU2476274720.SGD","LU0181495838.USD","BK1521","LU0417516902.SGD","09926","LU0561508036.HKD","BK4548","SG9999002463.SGD","LU0516423174.USD","LU1794554557.SGD","LU0052750758.USD","LU0327786744.USD","LU0348827113.USD","LU1688375341.USD","LU0348766576.USD","BK1161","LU0140636845.USD","LU0856984785.SGD","02269","LU2488822045.USD","LU1720050803.USD","LU2778985437.USD","LU0326950275.SGD","LU0348783233.USD","BK4526","BK1576","BK4531","BK4139","LU0823426480.USD","LU0708995583.HKD","LU0516423091.SGD","BK1574","LU1961090484.USD","LU0516422366.SGD","LU0819121731.USD","LU0348784397.USD","IE00B543WZ88.USD","LU0348825331.USD","LU0516422440.USD","LU0634319403.HKD","01548","SG9999002562.SGD","LU2476274308.USD","LU0588546209.SGD","HK0000320264.USD","IE00BPRC5H50.USD","LU2399975544.HKD","01477","LU0359201612.USD","IE00B5MMRT66.SGD","LU0359202008.SGD","LU0043850808.USD","LU0348735423.USD","09688","LU0039217434.USD","06978","01672","LU0540923850.HKD","LU3063872942.SGD","LU0516422952.EUR","LU0348767384.USD","BK1588","LU0417516738.SGD","LU0979878070.USD","BK1583","LU0051755006.USD"],"gpt_icon":0},{"id":"2590230583","title":"信达生物宣布IBI3011（抗人白细胞介素1受体辅助蛋白单克隆抗体，IL-1RAP）完成临床I期研究首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2590230583","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590230583?lang=zh_cn&edition=full","pubTime":"2025-12-10 08:26","pubTimestamp":1765326360,"startTime":"0","endTime":"0","summary":"美国旧金山和中国苏州2025年12月10日 /美通社/ --信达生物制药集团，一家致力于研发、生产和销售肿瘤、自免、代谢、眼科等重大疾病领域创新药物的生物制药公司，近日宣布其自主研发的抗人白细胞介素1受体辅助蛋白单克隆抗体在I期临床研究中完成首例受试者给药。人白细胞介素1受体辅助蛋白是IL-1家族的成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4842190_ZH42190_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2097828714.EUR","LU2488822045.USD","IVBIY","LU0455707207.USD","BK1161","LU1969619763.USD","BK1583","BK4139","LU2097828805.USD","LU2328871848.SGD","HK0000165453.HKD","LU2242644610.SGD","LU0502904849.HKD","LU2097828631.EUR","01801","LU2097828474.EUR","LU2097828557.USD","BK1589"],"gpt_icon":1},{"id":"1115187360","title":"Denali Therapeutics：拟发行并出售2亿美元普通股及部分投资者的认股权证","url":"https://stock-news.laohu8.com/highlight/detail?id=1115187360","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115187360?lang=zh_cn&edition=full","pubTime":"2025-12-10 05:16","pubTimestamp":1765314998,"startTime":"0","endTime":"0","summary":"Denali Therapeutics：拟发行并出售2亿美元普通股及部分投资者的认股权证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNLI","BK4535","BK4139","BK4548"],"gpt_icon":0},{"id":"1108126706","title":"Praxis Precision Medicines, Inc.：Embrave研究（A部分，N=9）的主要结果预计将在2026年上半年发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1108126706","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108126706?lang=zh_cn&edition=full","pubTime":"2025-12-10 05:03","pubTimestamp":1765314199,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc.：Embrave研究（A部分，N=9）的主要结果预计将在2026年上半年发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0109394709.USD","LU0889565916.HKD","LU0320765992.SGD","PRAX"],"gpt_icon":0},{"id":"1156451905","title":"Praxis Precision Medicines宣布与FDA达成一致，对Elsunersen在早发Scn2a发育性及癫痫性脑病的注册路径进行简化与加速","url":"https://stock-news.laohu8.com/highlight/detail?id=1156451905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156451905?lang=zh_cn&edition=full","pubTime":"2025-12-10 05:02","pubTimestamp":1765314150,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines宣布与FDA达成一致，对Elsunersen在早发Scn2a发育性及癫痫性脑病的注册路径进行简化与加速","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRAX","LU0889565916.HKD","LU0109394709.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"1196344993","title":"Praxis Precision Medicines, Inc.：FDA 同意对 Embrave3 试验设计进行拟议更改，成为单臂基线对照研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1196344993","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196344993?lang=zh_cn&edition=full","pubTime":"2025-12-10 05:02","pubTimestamp":1765314132,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc.：FDA 同意对 Embrave3 试验设计进行拟议更改，成为单臂基线对照研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","PRAX","LU0320765992.SGD","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2590329256","title":"Wedbush表示Sarepta的抛售“过度”。","url":"https://stock-news.laohu8.com/highlight/detail?id=2590329256","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590329256?lang=zh_cn&edition=full","pubTime":"2025-12-10 04:26","pubTimestamp":1765311960,"startTime":"0","endTime":"0","summary":"Sarepta（SRPT）美股周二尾盘上涨1.7%，此前券商Wedbush称Sarepta的股票抛售行为“过头了”。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-12-10/doc-inhahafp2378077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE0009355771.USD","IE00BJJMRZ35.SGD","SRPT","SINA","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4585","BK4139","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2590347834","title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590347834","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590347834?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:45","pubTimestamp":1765291511,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，Senti Biosciences(SNTI.US)开盘涨超7%，报2.54美元。消息面上，Senti Bio报告了更新的1期SENTI-202在R/R AML中的数据，显示50%的总缓解率(ORR)、42%的完全缓解/部分血液学缓解(CR/CRh)，且大多数为微小残留病阴性(MRD-Negative)持久应答，并获得RMAT支持以推进至关键研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"美股异动 | 1期SENTI-202试验数据积极 Senti Biosciences(SNTI.US)开盘涨超7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4539","BK4139","SNTI"],"gpt_icon":0},{"id":"2590334205","title":"纳斯达克中国金龙指数跌幅扩至1.74% 热门中概股普跌 传奇生物跌5.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590334205","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590334205?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:44","pubTimestamp":1765291499,"startTime":"0","endTime":"0","summary":"金吾财讯 | 纳斯达克中国金龙指数跌幅扩至1.74%，热门中概股普跌，传奇生物跌5.3%，贝壳跌4.74%，理想汽车、哔哩哔哩、名创优品跌近4%；涨幅方面，日月光半导体涨1.1%，亚玛芬体育涨0.83%，百胜中国涨0.09%。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MDI0ZTU2OTM1ZjEwZWVlMmRmOWY0NTEzNTY0MzU1MDg3.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MDI0ZTU2OTM1ZjEwZWVlMmRmOWY0NTEzNTY0MzU1MDg3.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"295210","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1051769294.HKD","BK4505","BK4566","BK4548","BK4554","BK4503","LU0326950275.SGD","BK4085","BK4079","LU1023057109.AUD","LU0359201885.HKD","BK4526","BK4513","BK4563","BK4139","LU0173614495.USD","BK4585","BK4510","EVS.SI","BK4114","BK4551","LU0287142896.SGD","LU1046422090.SGD","LU1515016050.SGD","LU0651947912.USD","LU0359201612.USD","HXC","LU0651946864.USD","LU1688375341.USD","LU0244354667.USD","LU1831875114.USD","LU0463099449.HKD","BK4509","BK4531","BK4588","LU0359202008.SGD","LU0274383008.USD","BK4555","BK4077","LU1051768304.USD","BK4099","BK4504","BK4220","BK4577","LU1188198961.HKD"],"gpt_icon":0},{"id":"1167465961","title":"XBiotech Inc. - John Simard将辞去XBiotech首席执行官职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1167465961","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167465961?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:18","pubTimestamp":1765289923,"startTime":"0","endTime":"0","summary":"12月9日（路透社）- XBiotech Inc.宣布：*XBIOTECH INC - JOHN SIMARD将辞去XBiotech首席执行官职务 - SEC文件*；*XBIOTECH INC - SUSHMA SHIVASWAMY被任命为XBiotech的临时首席执行官 - SEC文件*；*XBIOTECH INC - JOHN SIMARD将继续担任XBiotech董事会主席 - SEC文件*；*XBIOTECH - JOHN SIMARD将辞去首席执行官职务，但将继续担任董事会主席。*","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBIT","BK4139"],"gpt_icon":0},{"id":"1186772713","title":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1186772713","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186772713?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:33","pubTimestamp":1765287209,"startTime":"0","endTime":"0","summary":"Citius Oncology Inc - 直接发行以每股1.09美元购买1,284,404股普通股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","CTOR","CTXR"],"gpt_icon":0},{"id":"1111513577","title":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1111513577","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111513577?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:31","pubTimestamp":1765287103,"startTime":"0","endTime":"0","summary":"Citius Oncology 宣布以市场定价进行1800万美元的注册直销及私人投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTOR","CTXR","BK4007","BK4139"],"gpt_icon":0},{"id":"1189715386","title":"Moleculin宣布完成45名患者在关键“奇迹”第三阶段AML试验中的治疗，预计于2026年第一季度汇报进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1189715386","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189715386?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:07","pubTimestamp":1765285649,"startTime":"0","endTime":"0","summary":"Moleculin宣布完成45名患者在关键“奇迹”第三阶段AML试验中的治疗，预计于2026年第一季度汇报进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MBRX"],"gpt_icon":0},{"id":"1175573108","title":"塞德斯医疗启动巴佐洛单抗在冷荨麻疹和症状性皮肤划痕症中的全球注册三期研究计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1175573108","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175573108?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:05","pubTimestamp":1765285504,"startTime":"0","endTime":"0","summary":"塞德斯医疗启动巴佐洛单抗在冷荨麻疹和症状性皮肤划痕症中的全球注册三期研究计划","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDX","BK4139"],"gpt_icon":0},{"id":"1193463634","title":"Atossa Therapeutics宣布获得美国专利，涵盖肠溶口服（Z）-内酮芬配方及其治疗方法","url":"https://stock-news.laohu8.com/highlight/detail?id=1193463634","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193463634?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:04","pubTimestamp":1765285468,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics宣布获得美国专利，专利内容涉及肠溶口服（Z）-内酮芬配方及使用（Z）-内酮芬治疗患者的方法。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"1160199370","title":"Coya Therapeutics宣布患者已在Alstars试验中接受Coya 302治疗ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=1160199370","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160199370?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:03","pubTimestamp":1765285436,"startTime":"0","endTime":"0","summary":"Coya Therapeutics宣布患者已在Alstars试验中接受Coya 302治疗ALS","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"1118926247","title":"世纪治疗公司任命杰出生物技术领袖韩李博士和马丁穆菲博士为董事会成员","url":"https://stock-news.laohu8.com/highlight/detail?id=1118926247","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118926247?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:01","pubTimestamp":1765285278,"startTime":"0","endTime":"0","summary":"世纪治疗公司任命杰出生物技术领袖韩李博士和马丁穆菲博士为董事会成员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","IPSC","BK4505"],"gpt_icon":0},{"id":"1129245643","title":"关于Grifols价格目标标题的更正","url":"https://stock-news.laohu8.com/highlight/detail?id=1129245643","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129245643?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:26","pubTimestamp":1765283169,"startTime":"0","endTime":"0","summary":"“JP Morgan将Grifols的价格目标维持在每股10.00美元”于2025年12月8日11:17发布，原文错误表述价格目标从每股10.30美元下调至每股10.00美元。实际情况是价格目标维持在每股10.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRFS","BK4139"],"gpt_icon":0},{"id":"1103967501","title":"Biontech与施贵宝公布Pumitamig全球二期研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1103967501","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103967501?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:18","pubTimestamp":1765282713,"startTime":"0","endTime":"0","summary":"12月9日（路透社）- BioNTech SE与施贵宝首次公布PD-L1XVEGF-A双特异性抗体Pumitamig在晚期三阴性乳腺癌中的全球二期研究数据，显示出令人鼓舞的疗效。Pumitamig联合化疗实现了61.5%的确认客观反应率、71.8%的未确认客观反应率和92.3%的疾病控制率，与PD-L1表达水平无关。这些数据与先前在中国进行的1L TNBC I期/II期临床试验中报告的数据一致，并确认了关键III期ROSETTA BREAST-01试验的剂量选择。相关数据将于2025年圣安东尼奥乳腺癌研讨会上公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BK4534","LU2125154935.USD","BK4568","LU1585245621.USD","LU0321505439.SGD","LU0237698245.USD","BK4007","BK4559","BK4551","LU1670710588.SGD","BNTX","IE00BJT1NW94.SGD","BK4535","IE0002141913.USD","LU0225284248.USD","LU0882574055.USD","IE0009355771.USD","BK4548","LU1868836757.USD","LU1291159041.SGD","LU1718418525.SGD","LU1261432733.SGD","BK4588","IE00B2B36J28.USD","LU1868837300.USD","BK4139","LU1093756168.USD","LU1032466523.USD","BK4532","LU0225771236.USD","IE00BFXG1179.USD","LU1430594728.SGD","LU2133065610.SGD","LU0306806265.USD","LU0985481810.HKD","LU1670710661.SGD","LU1868836914.USD","LU0096364046.USD","LU2242646821.SGD","LU1074936037.SGD","LU1670711123.USD","LU1571399168.USD","LU1989771016.USD","BK4585","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU1093756325.SGD","LU1868836591.USD","LU2360032135.SGD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU1670711040.USD","LU0306807586.USD","LU0456855351.SGD","BMY","LU0061475181.USD","LU0868494617.USD","LU2242652126.USD","LU1868837136.USD","LU0267386448.USD","LU0321505868.SGD","BK4581"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.018},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.1313},{"period":"1year","weight":0.1296},{"period":"ytd","weight":0.1654}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}